跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
研究TGFBI訊號通路在攝護腺癌之荷爾蒙療法抗藥性與骨轉移的調控機制
Chen, Wei-Yu
(PI)
病理學科
研究計畫
:
A - 政府部門
›
b - 國家科學及技術委員會
概覽
指紋
指紋
探索此專案觸及的研究主題。這些標籤是根據基礎獎勵/補助款而產生。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Bone Metastasis
100%
Therapy Resistance
100%
Prostate Cancer
100%
Hormone Therapy
100%
Castration Resistant Prostate Cancer
63%
Androgen Receptor
63%
Gelatinase A
45%
Cancer Cell
36%
Androgen Deprivation Therapy
27%
Androgen Receptor Antagonist
18%
Cancer Growth
18%
Hypoxia
18%
Androgen
18%
Tumor
18%
Endothelial Cell
9%
In Vitro
9%
Metastatic Carcinoma
9%
Protein Expression
9%
Oxidative Stress
9%
Biological Functions
9%
Lymph Duct
9%
Cancer
9%
Cytokine
9%
Tumor Xenograft
9%
Extracellular Matrix
9%
Treatment Response
9%
Enzalutamide
9%
Metalloproteinase
9%
Messenger RNA
9%
Cancer Growth Factor
9%
Cell Signaling Pathway
9%
Neuroscience
Prostate
100%
Hormone Therapy
100%
Androgen Receptor
90%
MMP2
50%
Androgen
50%
CCL2
50%
Receptor Antagonist
20%
Metalloendopeptidase
10%
Enzalutamide
10%
In Vitro
10%
Messenger RNA
10%
Cancer Growth Factor
10%
Protein Expression
10%
Oxidative Stress
10%
Extracellular Matrix
10%
Cytokine
10%
In Vivo
10%
Cell Signaling
10%
Biochemistry, Genetics and Molecular Biology
Transforming Growth Factor Beta Induced
100%
Androgen Receptor
50%
CCL2
27%
MMP2
27%
Gelatinase A
27%
SPDEF
27%
Cancer Cell
22%
Gene Signature
11%
Receptor Antagonist
11%
Cytokine
5%
Messenger RNA
5%
Enzalutamide
5%
Biological Functions
5%
Oxidative Stress
5%
Metalloendopeptidase
5%
Metalloproteinase
5%
Cancer Growth Factor
5%
Protein Expression
5%
Regulatory Network
5%
Bioinformatics
5%